APOE and Alzheimer disease: Given that this decline over almost three decades precedes estimations of the functional manifestations of prodromal AD 38,39, continued follow-up of NSHD will determine the age-specific incidence of clinical dementia in those with the APOE-ε4 allele, in comparison to those without.